Stock Events

Stock Events

Capricor Therapeutics (4LN2.F) Q1 2026 Earnings

12MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.54

-0.45

-0.37

-0.28

Details

Expected EPS

-0.44188835

Actual EPS

-0.538253

Surprise EPS

-0.1

Surprise Percent

+21.81%

Description

Capricor Therapeutics (4LN2.F) has reported earnings of -0.538253 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.